185 related articles for article (PubMed ID: 18724016)
21. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
[TBL] [Abstract][Full Text] [Related]
22. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.
Chen C; Fu X; Li W; Jia X; Bai S; Geng W; Xing K
Exp Ther Med; 2015 Sep; 10(3):1059-1065. PubMed ID: 26622439
[TBL] [Abstract][Full Text] [Related]
23. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
24. Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".
Majidi M; Kosinski AS; Al-Khatib SM; Smolders L; Cristea E; Lansky AJ; Stone GW; Mehran R; Gibbons RJ; Crijns HJ; Wellens HJ; Gorgels AP; Krucoff MW
Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):51-9. PubMed ID: 25063574
[TBL] [Abstract][Full Text] [Related]
25. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
Choe JC; Oh JH; Lee HC; Lee JW; Park TS; Park JH; Kim E; Kim MS; Ahn J; Park JS; Lee HW; Choi JH; Cha KS
Acta Cardiol; 2023 Oct; 78(8):880-888. PubMed ID: 36942830
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
27. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
28. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
29. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
30. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
[No Abstract] [Full Text] [Related]
31. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
[TBL] [Abstract][Full Text] [Related]
32. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
33. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
34. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
35. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
[TBL] [Abstract][Full Text] [Related]
38. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
[TBL] [Abstract][Full Text] [Related]
39. Intracoronary nicorandil prior to reperfusion in acute myocardial infarction.
Miyazawa A; Ikari Y; Tanabe K; Nakajima H; Aoki J; Iijima R; Nakayama T; Hatori M; Nakazawa G; Tanimoto S; Onuma Y; Hara K
EuroIntervention; 2006 Aug; 2(2):211-7. PubMed ID: 19755263
[TBL] [Abstract][Full Text] [Related]
40. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Matsubara T; Murohara T
Diabetes Care; 2006 Feb; 29(2):202-6. PubMed ID: 16443860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
